These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15174968)

  • 1. Viral vectors for inducing CD8+ T cell responses.
    Truckenmiller ME; Norbury CC
    Expert Opin Biol Ther; 2004 Jun; 4(6):861-8. PubMed ID: 15174968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.
    Reimann J; Böhm W; Schirmbeck R
    Biol Chem Hoppe Seyler; 1994 Nov; 375(11):731-6. PubMed ID: 7535058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis.
    Chattergoon MA; Kim JJ; Yang JS; Robinson TM; Lee DJ; Dentchev T; Wilson DM; Ayyavoo V; Weiner DB
    Nat Biotechnol; 2000 Sep; 18(9):974-9. PubMed ID: 10973219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral vectors for gene transfer into antigen presenting cells.
    Monahan SJ; Salgaller ML
    Curr Opin Mol Ther; 1999 Oct; 1(5):558-64. PubMed ID: 11249662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming of CD8 T cells by adenoviral vectors is critically dependent on B7 and dendritic cells but only partially dependent on CD28 ligation on CD8 T cells.
    Nielsen KN; Steffensen MA; Christensen JP; Thomsen AR
    J Immunol; 2014 Aug; 193(3):1223-32. PubMed ID: 24951814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
    Steinman RM
    Mt Sinai J Med; 2001 May; 68(3):160-6. PubMed ID: 11373688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.
    Bathke B; Pätzold J; Kassub R; Giessel R; Lämmermann K; Hinterberger M; Brinkmann K; Chaplin P; Suter M; Hochrein H; Lauterbach H
    Immunology; 2018 Jun; 154(2):285-297. PubMed ID: 29281850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein.
    Gschoesser C; Almanzar G; Hainz U; Ortin J; Schonitzer D; Schild H; Saurwein-Teissl M; Grubeck-Loebenstein B
    Vaccine; 2002 Nov; 20(31-32):3731-8. PubMed ID: 12399202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
    Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
    J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity.
    Mosaheb MM; Dobrikova EY; Brown MC; Yang Y; Cable J; Okada H; Nair SK; Bigner DD; Ashley DM; Gromeier M
    Nat Commun; 2020 Jan; 11(1):524. PubMed ID: 31988324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.
    Tenbusch M; Nchinda G; Storcksdieck genannt Bonsmann M; Temchura V; Überla K
    Int Immunol; 2013 Apr; 25(4):247-58. PubMed ID: 23184617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of preexisting immunity to influenza on responses to influenza vectors in mice.
    Langley WA; Bradley KC; Li ZN; Talekar GR; Galloway SE; Steinhauer DA
    Vaccine; 2010 Aug; 28(38):6305-13. PubMed ID: 20656032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines.
    Gasteiger G; Kastenmuller W; Ljapoci R; Sutter G; Drexler I
    J Virol; 2007 Nov; 81(21):11925-36. PubMed ID: 17699574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design.
    Yewdell JW; Haeryfar SM
    Annu Rev Immunol; 2005; 23():651-82. PubMed ID: 15771583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.